{"transactions":[{"id":1720252,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-12-06T16:15:49.000Z","date":"2023-12-05","kind":"exercise","planned":false,"acquired":false,"shares":99442,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option is fully vested and exercisable."}],"balance_after":85080,"derivative":{"exercise_price":0.04,"expiration_date":"2024-11-11","underlying":"Common Stock","underlying_shares":99442},"source":{"system":"sec-edgar","filing":"0001209191-23-057600","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919123057600/doc4.xml","form_type":"4"}},{"id":1720251,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-12-06T16:15:49.000Z","date":"2023-12-04","kind":"exercise","planned":false,"acquired":false,"shares":25008,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option is fully vested and exercisable."}],"balance_after":184522,"derivative":{"exercise_price":0.04,"expiration_date":"2024-11-11","underlying":"Common Stock","underlying_shares":25008},"source":{"system":"sec-edgar","filing":"0001209191-23-057600","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919123057600/doc4.xml","form_type":"4"}},{"id":1720250,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-12-06T16:15:49.000Z","date":"2023-12-05","kind":"sale","planned":false,"acquired":false,"shares":99442,"price":5.17,"value":514115.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.00 to $5.27, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":333197,"source":{"system":"sec-edgar","filing":"0001209191-23-057600","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919123057600/doc4.xml","form_type":"4"}},{"id":1720249,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-12-06T16:15:49.000Z","date":"2023-12-05","kind":"exercise","planned":false,"acquired":true,"shares":99442,"price":0.04,"value":3977.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024."}],"balance_after":432639,"source":{"system":"sec-edgar","filing":"0001209191-23-057600","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919123057600/doc4.xml","form_type":"4"}},{"id":1720248,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-12-06T16:15:49.000Z","date":"2023-12-04","kind":"sale","planned":false,"acquired":false,"shares":25008,"price":5.01,"value":125290.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.00 to $5.03, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":333197,"source":{"system":"sec-edgar","filing":"0001209191-23-057600","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919123057600/doc4.xml","form_type":"4"}},{"id":1720247,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-12-06T16:15:49.000Z","date":"2023-12-04","kind":"exercise","planned":false,"acquired":true,"shares":25008,"price":0.04,"value":1000.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024."}],"balance_after":358205,"source":{"system":"sec-edgar","filing":"0001209191-23-057600","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919123057600/doc4.xml","form_type":"4"}},{"id":1725663,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-12-01T17:14:26.000Z","date":"2023-12-01","kind":"exercise","planned":false,"acquired":false,"shares":20200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is fully vested and exercisable."}],"balance_after":209530,"derivative":{"exercise_price":0.04,"expiration_date":"2024-11-11","underlying":"Common Stock","underlying_shares":20200},"source":{"system":"sec-edgar","filing":"0001209191-23-057093","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919123057093/doc4.xml","form_type":"4"}},{"id":1725662,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-12-01T17:14:26.000Z","date":"2023-11-29","kind":"exercise","planned":false,"acquired":false,"shares":5350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is fully vested and exercisable."}],"balance_after":229730,"derivative":{"exercise_price":0.04,"expiration_date":"2024-11-11","underlying":"Common Stock","underlying_shares":5350},"source":{"system":"sec-edgar","filing":"0001209191-23-057093","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919123057093/doc4.xml","form_type":"4"}},{"id":1725661,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-12-01T17:14:26.000Z","date":"2023-12-01","kind":"sale","planned":false,"acquired":false,"shares":20200,"price":5,"value":101000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024."}],"balance_after":333197,"source":{"system":"sec-edgar","filing":"0001209191-23-057093","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919123057093/doc4.xml","form_type":"4"}},{"id":1725660,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-12-01T17:14:26.000Z","date":"2023-12-01","kind":"exercise","planned":false,"acquired":true,"shares":20200,"price":0.04,"value":808.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024."}],"balance_after":353397,"source":{"system":"sec-edgar","filing":"0001209191-23-057093","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919123057093/doc4.xml","form_type":"4"}},{"id":1725659,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-12-01T17:14:26.000Z","date":"2023-11-29","kind":"sale","planned":false,"acquired":false,"shares":5350,"price":5,"value":26750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.00 to $5.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":333197,"source":{"system":"sec-edgar","filing":"0001209191-23-057093","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919123057093/doc4.xml","form_type":"4"}},{"id":1725658,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-12-01T17:14:26.000Z","date":"2023-11-29","kind":"exercise","planned":false,"acquired":true,"shares":5350,"price":0.04,"value":214.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024."}],"balance_after":338547,"source":{"system":"sec-edgar","filing":"0001209191-23-057093","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919123057093/doc4.xml","form_type":"4"}},{"id":1831035,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-07-12T18:06:20.000Z","date":"2023-07-12","kind":"exercise","planned":true,"acquired":false,"shares":16757,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option is fully vested and exercisable."}],"balance_after":235080,"derivative":{"exercise_price":0.04,"expiration_date":"2024-11-11","underlying":"Common Stock","underlying_shares":16757},"source":{"system":"sec-edgar","filing":"0001209191-23-042110","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919123042110/doc4.xml","form_type":"4"}},{"id":1831034,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-07-12T18:06:20.000Z","date":"2023-07-11","kind":"exercise","planned":true,"acquired":false,"shares":12798,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option is fully vested and exercisable."}],"balance_after":251837,"derivative":{"exercise_price":0.04,"expiration_date":"2024-11-11","underlying":"Common Stock","underlying_shares":12798},"source":{"system":"sec-edgar","filing":"0001209191-23-042110","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919123042110/doc4.xml","form_type":"4"}},{"id":1831033,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-07-12T18:06:20.000Z","date":"2023-07-10","kind":"exercise","planned":true,"acquired":false,"shares":445,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option is fully vested and exercisable."}],"balance_after":264635,"derivative":{"exercise_price":0.04,"expiration_date":"2024-11-11","underlying":"Common Stock","underlying_shares":445},"source":{"system":"sec-edgar","filing":"0001209191-23-042110","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919123042110/doc4.xml","form_type":"4"}},{"id":1831032,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-07-12T18:06:20.000Z","date":"2023-07-12","kind":"sale","planned":true,"acquired":false,"shares":16757,"price":5.02,"value":84120.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.00 to $5.12, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":333197,"source":{"system":"sec-edgar","filing":"0001209191-23-042110","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919123042110/doc4.xml","form_type":"4"}},{"id":1831031,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-07-12T18:06:20.000Z","date":"2023-07-12","kind":"exercise","planned":true,"acquired":true,"shares":16757,"price":0.04,"value":670.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024."}],"balance_after":349954,"source":{"system":"sec-edgar","filing":"0001209191-23-042110","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919123042110/doc4.xml","form_type":"4"}},{"id":1831030,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-07-12T18:06:20.000Z","date":"2023-07-11","kind":"sale","planned":true,"acquired":false,"shares":12798,"price":5.04,"value":64501.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.00 to $5.085, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":333197,"source":{"system":"sec-edgar","filing":"0001209191-23-042110","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919123042110/doc4.xml","form_type":"4"}},{"id":1831029,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-07-12T18:06:20.000Z","date":"2023-07-11","kind":"exercise","planned":true,"acquired":true,"shares":12798,"price":0.04,"value":511.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024."}],"balance_after":345995,"source":{"system":"sec-edgar","filing":"0001209191-23-042110","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919123042110/doc4.xml","form_type":"4"}},{"id":1831028,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-07-12T18:06:20.000Z","date":"2023-07-10","kind":"sale","planned":true,"acquired":false,"shares":445,"price":5.01,"value":2229.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.005 to $5.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":333197,"source":{"system":"sec-edgar","filing":"0001209191-23-042110","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919123042110/doc4.xml","form_type":"4"}},{"id":1831027,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-07-12T18:06:20.000Z","date":"2023-07-10","kind":"exercise","planned":true,"acquired":true,"shares":445,"price":0.04,"value":17.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024."}],"balance_after":333642,"source":{"system":"sec-edgar","filing":"0001209191-23-042110","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919123042110/doc4.xml","form_type":"4"}},{"id":1854672,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-06-15T16:30:22.000Z","date":"2023-06-14","kind":"exercise","planned":true,"acquired":false,"shares":28883,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option is fully vested and exercisable."}],"balance_after":265080,"derivative":{"exercise_price":0.04,"expiration_date":"2024-11-11","underlying":"Common Stock","underlying_shares":28883},"source":{"system":"sec-edgar","filing":"0001209191-23-037358","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919123037358/doc4.xml","form_type":"4"}},{"id":1854671,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-06-15T16:30:22.000Z","date":"2023-06-13","kind":"exercise","planned":true,"acquired":false,"shares":14968,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option is fully vested and exercisable."}],"balance_after":293963,"derivative":{"exercise_price":0.04,"expiration_date":"2024-11-11","underlying":"Common Stock","underlying_shares":14968},"source":{"system":"sec-edgar","filing":"0001209191-23-037358","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919123037358/doc4.xml","form_type":"4"}},{"id":1854670,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-06-15T16:30:22.000Z","date":"2023-06-14","kind":"sale","planned":true,"acquired":false,"shares":28883,"price":5.04,"value":145570.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.00 to $5.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":333197,"source":{"system":"sec-edgar","filing":"0001209191-23-037358","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919123037358/doc4.xml","form_type":"4"}},{"id":1854669,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-06-15T16:30:22.000Z","date":"2023-06-14","kind":"exercise","planned":true,"acquired":true,"shares":28883,"price":0.04,"value":1155.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024."}],"balance_after":362080,"source":{"system":"sec-edgar","filing":"0001209191-23-037358","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919123037358/doc4.xml","form_type":"4"}},{"id":1854668,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-06-15T16:30:22.000Z","date":"2023-06-13","kind":"sale","planned":true,"acquired":false,"shares":14968,"price":5.03,"value":75289.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.00 to $5.115, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":333197,"source":{"system":"sec-edgar","filing":"0001209191-23-037358","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919123037358/doc4.xml","form_type":"4"}},{"id":1854667,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-06-15T16:30:22.000Z","date":"2023-06-13","kind":"exercise","planned":true,"acquired":true,"shares":14968,"price":0.04,"value":598.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024."}],"balance_after":348165,"source":{"system":"sec-edgar","filing":"0001209191-23-037358","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919123037358/doc4.xml","form_type":"4"}},{"id":1903043,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-05-05T17:09:13.000Z","date":"2023-05-03","kind":"exercise","planned":true,"acquired":false,"shares":16149,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is fully vested and exercisable."}],"balance_after":308931,"derivative":{"exercise_price":0.04,"expiration_date":"2024-11-11","underlying":"Common Stock","underlying_shares":16149},"source":{"system":"sec-edgar","filing":"0001209191-23-027781","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919123027781/doc4.xml","form_type":"4"}},{"id":1903042,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-05-05T17:09:13.000Z","date":"2023-05-03","kind":"sale","planned":true,"acquired":false,"shares":16149,"price":5.02,"value":81067.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.00 to $5.03, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":333197,"source":{"system":"sec-edgar","filing":"0001209191-23-027781","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919123027781/doc4.xml","form_type":"4"}},{"id":1903041,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-05-05T17:09:13.000Z","date":"2023-05-03","kind":"exercise","planned":true,"acquired":true,"shares":16149,"price":0.04,"value":645.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024."}],"balance_after":349346,"source":{"system":"sec-edgar","filing":"0001209191-23-027781","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919123027781/doc4.xml","form_type":"4"}},{"id":1921144,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-04-12T16:37:28.000Z","date":"2023-04-12","kind":"exercise","planned":true,"acquired":false,"shares":12718,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option is fully vested and exercisable."}],"balance_after":325080,"derivative":{"exercise_price":0.04,"expiration_date":"2024-11-11","underlying":"Common Stock","underlying_shares":12718},"source":{"system":"sec-edgar","filing":"0001209191-23-024097","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919123024097/doc4.xml","form_type":"4"}},{"id":1921143,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-04-12T16:37:28.000Z","date":"2023-04-11","kind":"exercise","planned":true,"acquired":false,"shares":2182,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option is fully vested and exercisable."}],"balance_after":337798,"derivative":{"exercise_price":0.04,"expiration_date":"2024-11-11","underlying":"Common Stock","underlying_shares":2182},"source":{"system":"sec-edgar","filing":"0001209191-23-024097","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919123024097/doc4.xml","form_type":"4"}},{"id":1921142,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-04-12T16:37:28.000Z","date":"2023-04-10","kind":"exercise","planned":true,"acquired":false,"shares":100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option is fully vested and exercisable."}],"balance_after":339980,"derivative":{"exercise_price":0.04,"expiration_date":"2024-11-11","underlying":"Common Stock","underlying_shares":100},"source":{"system":"sec-edgar","filing":"0001209191-23-024097","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919123024097/doc4.xml","form_type":"4"}},{"id":1921141,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-04-12T16:37:28.000Z","date":"2023-04-12","kind":"sale","planned":true,"acquired":false,"shares":12718,"price":5,"value":63590.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.00 to $5.001, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":333197,"source":{"system":"sec-edgar","filing":"0001209191-23-024097","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919123024097/doc4.xml","form_type":"4"}},{"id":1921140,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-04-12T16:37:28.000Z","date":"2023-04-12","kind":"exercise","planned":true,"acquired":true,"shares":12718,"price":0.04,"value":508.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024."}],"balance_after":345915,"source":{"system":"sec-edgar","filing":"0001209191-23-024097","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919123024097/doc4.xml","form_type":"4"}},{"id":1921139,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-04-12T16:37:28.000Z","date":"2023-04-11","kind":"sale","planned":true,"acquired":false,"shares":2182,"price":5,"value":10910.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.00 to $5.025, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":333197,"source":{"system":"sec-edgar","filing":"0001209191-23-024097","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919123024097/doc4.xml","form_type":"4"}},{"id":1921138,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-04-12T16:37:28.000Z","date":"2023-04-11","kind":"exercise","planned":true,"acquired":true,"shares":2182,"price":0.04,"value":87.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024."}],"balance_after":335379,"source":{"system":"sec-edgar","filing":"0001209191-23-024097","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919123024097/doc4.xml","form_type":"4"}},{"id":1921137,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-04-12T16:37:28.000Z","date":"2023-04-10","kind":"sale","planned":true,"acquired":false,"shares":100,"price":5,"value":500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024."}],"balance_after":333197,"source":{"system":"sec-edgar","filing":"0001209191-23-024097","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919123024097/doc4.xml","form_type":"4"}},{"id":1921136,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-04-12T16:37:28.000Z","date":"2023-04-10","kind":"exercise","planned":true,"acquired":true,"shares":100,"price":0.04,"value":4.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024."}],"balance_after":333297,"source":{"system":"sec-edgar","filing":"0001209191-23-024097","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919123024097/doc4.xml","form_type":"4"}},{"id":1923084,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-04-07T16:42:29.000Z","date":"2023-04-06","kind":"exercise","planned":true,"acquired":false,"shares":27862,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option is fully vested and exercisable."}],"balance_after":340080,"derivative":{"exercise_price":0.04,"expiration_date":"2024-11-11","underlying":"Common Stock","underlying_shares":27862},"source":{"system":"sec-edgar","filing":"0001209191-23-023806","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919123023806/doc4.xml","form_type":"4"}},{"id":1923083,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-04-07T16:42:29.000Z","date":"2023-04-05","kind":"exercise","planned":true,"acquired":false,"shares":6961,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option is fully vested and exercisable."}],"balance_after":367942,"derivative":{"exercise_price":0.04,"expiration_date":"2024-11-11","underlying":"Common Stock","underlying_shares":6961},"source":{"system":"sec-edgar","filing":"0001209191-23-023806","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919123023806/doc4.xml","form_type":"4"}},{"id":1923082,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-04-07T16:42:29.000Z","date":"2023-04-06","kind":"sale","planned":true,"acquired":false,"shares":27862,"price":5.03,"value":140145.86,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.00 to $5.09, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":333197,"source":{"system":"sec-edgar","filing":"0001209191-23-023806","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919123023806/doc4.xml","form_type":"4"}},{"id":1923081,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-04-07T16:42:29.000Z","date":"2023-04-06","kind":"exercise","planned":true,"acquired":true,"shares":27862,"price":0.04,"value":1114.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024."}],"balance_after":361059,"source":{"system":"sec-edgar","filing":"0001209191-23-023806","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919123023806/doc4.xml","form_type":"4"}},{"id":1923080,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-04-07T16:42:29.000Z","date":"2023-04-05","kind":"sale","planned":true,"acquired":false,"shares":6961,"price":5,"value":34805.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.00 to $5.03, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":333197,"source":{"system":"sec-edgar","filing":"0001209191-23-023806","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919123023806/doc4.xml","form_type":"4"}},{"id":1923079,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-04-07T16:42:29.000Z","date":"2023-04-05","kind":"exercise","planned":true,"acquired":true,"shares":6961,"price":0.04,"value":278.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024."}],"balance_after":340158,"source":{"system":"sec-edgar","filing":"0001209191-23-023806","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919123023806/doc4.xml","form_type":"4"}},{"id":1928946,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-04-04T18:59:20.000Z","date":"2023-04-04","kind":"exercise","planned":true,"acquired":false,"shares":7470,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option is fully vested and exercisable."}],"balance_after":374903,"derivative":{"exercise_price":0.04,"expiration_date":"2024-11-11","underlying":"Common Stock","underlying_shares":7470},"source":{"system":"sec-edgar","filing":"0001209191-23-022983","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919123022983/doc4.xml","form_type":"4"}},{"id":1928945,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-04-04T18:59:20.000Z","date":"2023-04-03","kind":"exercise","planned":true,"acquired":false,"shares":100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option is fully vested and exercisable."}],"balance_after":382373,"derivative":{"exercise_price":0.04,"expiration_date":"2024-11-11","underlying":"Common Stock","underlying_shares":100},"source":{"system":"sec-edgar","filing":"0001209191-23-022983","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919123022983/doc4.xml","form_type":"4"}},{"id":1928944,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-04-04T18:59:20.000Z","date":"2023-03-31","kind":"exercise","planned":true,"acquired":false,"shares":2607,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option is fully vested and exercisable."}],"balance_after":382473,"derivative":{"exercise_price":0.04,"expiration_date":"2024-11-11","underlying":"Common Stock","underlying_shares":2607},"source":{"system":"sec-edgar","filing":"0001209191-23-022983","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919123022983/doc4.xml","form_type":"4"}},{"id":1928943,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-04-04T18:59:20.000Z","date":"2023-04-04","kind":"sale","planned":true,"acquired":false,"shares":7470,"price":5.03,"value":37574.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.00 to $5.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":333197,"source":{"system":"sec-edgar","filing":"0001209191-23-022983","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919123022983/doc4.xml","form_type":"4"}},{"id":1928942,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-04-04T18:59:20.000Z","date":"2023-04-04","kind":"exercise","planned":true,"acquired":true,"shares":7470,"price":0.04,"value":298.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024."}],"balance_after":340667,"source":{"system":"sec-edgar","filing":"0001209191-23-022983","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919123022983/doc4.xml","form_type":"4"}},{"id":1928941,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-04-04T18:59:20.000Z","date":"2023-04-03","kind":"sale","planned":true,"acquired":false,"shares":100,"price":5.01,"value":501.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024."}],"balance_after":333197,"source":{"system":"sec-edgar","filing":"0001209191-23-022983","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919123022983/doc4.xml","form_type":"4"}},{"id":1928940,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-04-04T18:59:20.000Z","date":"2023-04-03","kind":"exercise","planned":true,"acquired":true,"shares":100,"price":0.04,"value":4.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024."}],"balance_after":333297,"source":{"system":"sec-edgar","filing":"0001209191-23-022983","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919123022983/doc4.xml","form_type":"4"}},{"id":1928939,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-04-04T18:59:20.000Z","date":"2023-03-31","kind":"sale","planned":true,"acquired":false,"shares":2607,"price":5,"value":13035.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.00 to $5.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":333197,"source":{"system":"sec-edgar","filing":"0001209191-23-022983","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919123022983/doc4.xml","form_type":"4"}},{"id":1928938,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-04-04T18:59:20.000Z","date":"2023-03-31","kind":"exercise","planned":true,"acquired":true,"shares":2607,"price":0.04,"value":104.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024."}],"balance_after":335804,"source":{"system":"sec-edgar","filing":"0001209191-23-022983","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919123022983/doc4.xml","form_type":"4"}},{"id":1943278,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-03-21T16:42:14.000Z","date":"2023-03-20","kind":"grant","planned":false,"acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying this option vest on March 20, 2024 and the remaining 75% vest in 36 equal monthly installments thereafter, subject to the reporting person's continuous service with the Issuer at each vesting date."}],"balance_after":400000,"derivative":{"exercise_price":4.19,"expiration_date":"2033-03-19","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001209191-23-020285","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919123020285/doc4.xml","form_type":"4"}},{"id":2033423,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-02-03T16:31:55.000Z","date":"2023-02-02","kind":"exercise","acquired":false,"shares":10665,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option is fully vested and exercisable."}],"balance_after":385080,"derivative":{"exercise_price":0.04,"expiration_date":"2024-11-11","underlying":"Common Stock","underlying_shares":10665},"source":{"system":"sec-edgar","filing":"0001209191-23-006876","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919123006876/doc4.xml","form_type":"4"}},{"id":2033422,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-02-03T16:31:55.000Z","date":"2023-02-01","kind":"exercise","acquired":false,"shares":19335,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option is fully vested and exercisable."}],"balance_after":395745,"derivative":{"exercise_price":0.04,"expiration_date":"2024-11-11","underlying":"Common Stock","underlying_shares":19335},"source":{"system":"sec-edgar","filing":"0001209191-23-006876","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919123006876/doc4.xml","form_type":"4"}},{"id":2033421,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-02-03T16:31:55.000Z","date":"2023-02-02","kind":"sale","acquired":false,"shares":10665,"price":5.77,"value":61537.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.69 to $5.885, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":333197,"source":{"system":"sec-edgar","filing":"0001209191-23-006876","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919123006876/doc4.xml","form_type":"4"}},{"id":2033420,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-02-03T16:31:55.000Z","date":"2023-02-02","kind":"exercise","acquired":true,"shares":10665,"price":0.04,"value":426.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024."}],"balance_after":343862,"source":{"system":"sec-edgar","filing":"0001209191-23-006876","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919123006876/doc4.xml","form_type":"4"}},{"id":2033419,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-02-03T16:31:55.000Z","date":"2023-02-01","kind":"sale","acquired":false,"shares":19335,"price":5.69,"value":110016.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.50 to $5.85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":333197,"source":{"system":"sec-edgar","filing":"0001209191-23-006876","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919123006876/doc4.xml","form_type":"4"}},{"id":2033418,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-02-03T16:31:55.000Z","date":"2023-02-01","kind":"exercise","acquired":true,"shares":19335,"price":0.04,"value":773.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024."}],"balance_after":352532,"source":{"system":"sec-edgar","filing":"0001209191-23-006876","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919123006876/doc4.xml","form_type":"4"}},{"id":2063134,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-01-05T17:39:02.000Z","date":"2023-01-05","kind":"exercise","acquired":false,"shares":10234,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option is fully vested and exercisable."}],"balance_after":415080,"derivative":{"exercise_price":0.04,"expiration_date":"2024-11-11","underlying":"Common Stock","underlying_shares":10234},"source":{"system":"sec-edgar","filing":"0001209191-23-001995","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919123001995/doc4.xml","form_type":"4"}},{"id":2063133,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-01-05T17:39:02.000Z","date":"2023-01-04","kind":"exercise","acquired":false,"shares":9153,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option is fully vested and exercisable."}],"balance_after":425314,"derivative":{"exercise_price":0.04,"expiration_date":"2024-11-11","underlying":"Common Stock","underlying_shares":9153},"source":{"system":"sec-edgar","filing":"0001209191-23-001995","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919123001995/doc4.xml","form_type":"4"}},{"id":2063132,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-01-05T17:39:02.000Z","date":"2023-01-03","kind":"exercise","acquired":false,"shares":10613,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option is fully vested and exercisable."}],"balance_after":434467,"derivative":{"exercise_price":0.04,"expiration_date":"2024-11-11","underlying":"Common Stock","underlying_shares":10613},"source":{"system":"sec-edgar","filing":"0001209191-23-001995","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919123001995/doc4.xml","form_type":"4"}},{"id":2063131,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-01-05T17:39:02.000Z","date":"2023-01-05","kind":"sale","acquired":false,"shares":10234,"price":5.04,"value":51579.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.00 to $5.14, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":333197,"source":{"system":"sec-edgar","filing":"0001209191-23-001995","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919123001995/doc4.xml","form_type":"4"}},{"id":2063130,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-01-05T17:39:02.000Z","date":"2023-01-05","kind":"exercise","acquired":true,"shares":10234,"price":0.04,"value":409.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024."}],"balance_after":343431,"source":{"system":"sec-edgar","filing":"0001209191-23-001995","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919123001995/doc4.xml","form_type":"4"}},{"id":2063129,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-01-05T17:39:02.000Z","date":"2023-01-04","kind":"sale","acquired":false,"shares":9153,"price":5.07,"value":46405.71,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.00 to $5.19, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":333197,"source":{"system":"sec-edgar","filing":"0001209191-23-001995","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919123001995/doc4.xml","form_type":"4"}},{"id":2063128,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-01-05T17:39:02.000Z","date":"2023-01-04","kind":"exercise","acquired":true,"shares":9153,"price":0.04,"value":366.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024."}],"balance_after":342350,"source":{"system":"sec-edgar","filing":"0001209191-23-001995","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919123001995/doc4.xml","form_type":"4"}},{"id":2063127,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-01-05T17:39:02.000Z","date":"2023-01-03","kind":"sale","acquired":false,"shares":10613,"price":5.13,"value":54444.69,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.00 to $5.49, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":333197,"source":{"system":"sec-edgar","filing":"0001209191-23-001995","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919123001995/doc4.xml","form_type":"4"}},{"id":2063126,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-01-05T17:39:02.000Z","date":"2023-01-03","kind":"exercise","acquired":true,"shares":10613,"price":0.04,"value":424.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024."}],"balance_after":343810,"source":{"system":"sec-edgar","filing":"0001209191-23-001995","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919123001995/doc4.xml","form_type":"4"}},{"id":2315571,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-03-29T16:15:46.000Z","date":"2022-03-25","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying this option vest on March 25, 2023 and the remaining 75% vest in 36 equal monthly installments thereafter, subject to the reporting person's continuous service with the Issuer at each vesting date."}],"balance_after":500000,"derivative":{"exercise_price":7.12,"expiration_date":"2032-03-24","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001209191-22-021460","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919122021460/doc4.xml","form_type":"4"}},{"id":2511096,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-11-16T19:08:22.000Z","date":"2021-11-16","kind":"exercise","acquired":false,"shares":74890,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option is fully vested and exercisable."}],"balance_after":445080,"derivative":{"exercise_price":0.04,"expiration_date":"2024-11-11","underlying":"Common Stock","underlying_shares":74890},"source":{"system":"sec-edgar","filing":"0001209191-21-064875","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919121064875/doc4.xml","form_type":"4"}},{"id":2511095,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-11-16T19:08:22.000Z","date":"2021-11-15","kind":"exercise","acquired":false,"shares":123263,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option is fully vested and exercisable."}],"balance_after":519970,"derivative":{"exercise_price":0.04,"expiration_date":"2024-11-11","underlying":"Common Stock","underlying_shares":123263},"source":{"system":"sec-edgar","filing":"0001209191-21-064875","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919121064875/doc4.xml","form_type":"4"}},{"id":2511094,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-11-16T19:08:22.000Z","date":"2021-11-12","kind":"exercise","acquired":false,"shares":1847,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option is fully vested and exercisable."}],"balance_after":643233,"derivative":{"exercise_price":0.04,"expiration_date":"2024-11-11","underlying":"Common Stock","underlying_shares":1847},"source":{"system":"sec-edgar","filing":"0001209191-21-064875","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919121064875/doc4.xml","form_type":"4"}},{"id":2511093,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-11-16T19:08:22.000Z","date":"2021-11-16","kind":"sale","acquired":false,"shares":74890,"price":12.08,"value":904671.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $12.00 to $12.20, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":333197,"source":{"system":"sec-edgar","filing":"0001209191-21-064875","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919121064875/doc4.xml","form_type":"4"}},{"id":2511092,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-11-16T19:08:22.000Z","date":"2021-11-16","kind":"exercise","acquired":true,"shares":74890,"price":0.04,"value":2995.6,"ownership":{"direct":true},"balance_after":408087,"source":{"system":"sec-edgar","filing":"0001209191-21-064875","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919121064875/doc4.xml","form_type":"4"}},{"id":2511091,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-11-16T19:08:22.000Z","date":"2021-11-15","kind":"sale","acquired":false,"shares":123263,"price":12.16,"value":1498878.08,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $12.03 to $12.615, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":333197,"source":{"system":"sec-edgar","filing":"0001209191-21-064875","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919121064875/doc4.xml","form_type":"4"}},{"id":2511090,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-11-16T19:08:22.000Z","date":"2021-11-15","kind":"exercise","acquired":true,"shares":123263,"price":0.04,"value":4930.52,"ownership":{"direct":true},"balance_after":456460,"source":{"system":"sec-edgar","filing":"0001209191-21-064875","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919121064875/doc4.xml","form_type":"4"}},{"id":2511089,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-11-16T19:08:22.000Z","date":"2021-11-12","kind":"sale","acquired":false,"shares":101847,"price":12.66,"value":1289383.02,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $12.56 to $12.765, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":333197,"source":{"system":"sec-edgar","filing":"0001209191-21-064875","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919121064875/doc4.xml","form_type":"4"}},{"id":2511088,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-11-16T19:08:22.000Z","date":"2021-11-12","kind":"exercise","acquired":true,"shares":1847,"price":0.04,"value":73.88,"ownership":{"direct":true},"balance_after":435044,"source":{"system":"sec-edgar","filing":"0001209191-21-064875","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919121064875/doc4.xml","form_type":"4"}},{"id":2607156,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":107715,"kind":"person","name":"Doerfler Douglas","position":1,"cik":"0001874482","reported_name":"Doerfler Douglas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2021-08-11T17:11:50.000Z","date":"2021-08-09","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying the option vest on August 9, 2022 and the remaining shares underlying the option vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service with the Issuer at each vesting date."}],"balance_after":10000,"derivative":{"exercise_price":16.63,"expiration_date":"2031-08-09","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-21-050928","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874482/000120919121050928/doc4.xml","form_type":"4"}}]}